TBPH

Q: What is the price of Theravance Biopharma (TBPH) today?

The price of Theravance Biopharma (TBPH) today is $ 14.17, with a variation of 63.82% compared to the last year. The price of Theravance Biopharma (TBPH) started the year trading around $ 9.41 and today it is at $ 14.17. Follow the real-time price chart, the historical price of Theravance Biopharma (TBPH) and international markets.

Q: When does Theravance Biopharma (TBPH) pay dividends?

Theravance Biopharma (TBPH) did not distribute dividends in the last year.

Q: Is Theravance Biopharma (TBPH) worth it?

Currently, Theravance Biopharma (TBPH) is priced at $ 14.17, with a P/E of 54.80%%, representing a deviation of 670%% from its historical average P/E. In the last year, the stock showed a variation of 63.82% in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%%. The total shareholder return was 63.82%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Theravance Biopharma (TBPH) stock?

Investing in stocks of Theravance Biopharma (TBPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Theravance Biopharma (TBPH) yield today?

The yield of Theravance Biopharma (TBPH) was -1.80% in the last month, 63.82% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%%.If you wanted to buy 100 stocks of Theravance Biopharma (TBPH) today, the total investment would be $ 1,417.00, based on the current price of $ 14.17.If past performance were to repeat, the return on your investment would be:In 1 year: $ 2,321.33In 5 years: $ 1,417.00In 10 years: $ 1,417.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Theravance Biopharma Inc.

Price

$ 14.17

variation (12m)

63.82%

p/e

54.80

p/bv

3.18

DIVIDEND YIELD

0.00%

price TBPH

BVMF

TBPH

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of TBPH

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-1.80%

3 months

26.97%

1 year

63.82%

2 years

52.37%

5 years

0.00%

10 years

0.00%

Indicators TBPH

check out the fundamentals of Theravance Biopharma shares

P/E

54.80

Sector: -2.39 Industry: -4.05

P/SALES RATIO (PSR)

9.25

Sector: 2.06 Industry: 3.02

P/BV

3.18

Sector: 2.22 Industry: 1.82

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

3.06%

Sector: -27.91% Industry: -56.46%

ROE

5.79%

Sector: -32.72% Industry: -45.65%

ROIC

-5.94%

Sector: -403.81% Industry: -420.03%

NET MARGIN

16.88%

Sector: -27.27% Industry: -32.68%

GROSS MARGIN

100.00%

Sector: 44.14% Industry: 45.05%

OPERATING MARGIN

-46.16%

Sector: -23.95% Industry: -30.16%

P/EBITDA

15.99

Sector: -0.73 Industry: -3.02

P/EBIT

16.74

Sector: -2.40 Industry: -3.57

P/ASSET

1.68

Sector: 1.28 Industry: 1.40

BVPS

4.50

Sector: 3.53 Industry: 1.64

EPS

0.26

Sector: -0.82 Industry: -1.24

EQUITY / ASSETS

0.53

Sector: 0.44 Industry: 0.48

CAGR REVENUES 5 YEARS

1.45%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0.00%

Sector: - Industry: -

FAIR PRICE OF Theravance Biopharma ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 14.17

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-63.79%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

TBPH indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market value	net margin
LLY	53.71	40.40	75.21%	0.70%	$ 741.25 B	25.91%
ISRG	71.03	11.45	16.12%	0.00%	$ 195.10 B	28.58%
TMO	32.94	4.23	12.84%	0.29%	$ 216.41 B	15.02%
SNY	11.23	1.56	13.90%	4.28%	$ 126.57 B	14.83%
MDT	25.77	2.49	9.68%	3.01%	$ 120.08 B	13.63%
CVS	22.89	1.34	5.84%	3.25%	$ 103.72 B	1.17%
ABT	15.96	4.39	27.50%	1.81%	$ 223.05 B	32.43%
NVS	18.60	6.04	32.47%	2.97%	$ 253.94 B	24.74%
GSK	19.51	4.51	23.12%	3.81%	$ 87.86 B	10.87%
BSX	53.67	0.00	0.00%	0.00%	$ 149.85 B	14.43%
TMDX	61.92	13.95	22.53%	0.00%	$ 4.44 B	13.49%
HCA	18.04	-87.02	-482.31%	0.63%	$ 107.74 B	8.21%
DHR	45.18	3.10	6.86%	0.41%	$ 158.28 B	14.43%
IDXX	52.01	35.14	67.57%	0.00%	$ 51.27 B	24.41%
INMD	5.40	1.53	28.44%	0.00%	$ 964.53 M	44.50%
FMS	21.91	0.97	4.42%	2.89%	$ 15.99 B	3.41%
PHG	129.84	2.27	1.75%	3.07%	$ 27.28 B	1.07%
HUM	22.32	1.92	8.61%	0.91%	$ 35.17 B	1.28%
RMD	27.05	6.35	23.47%	0.84%	$ 37.89 B	27.22%

comparison of TBPH with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History TBPH

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Theravance Biopharma

Theravance Biopharma Inc.

Average user rating I10

4.0 (2 people)

Estados Unidos

12 years

Foundation: 2013

2014

Year of debut on the stock exchange - 11 years

359

Employees

The Company Theravance Biopharma Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 714.00 Millions, having a net worth of $ 224.85 Millions.

With a total of 359 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 77.21 Millions, which generated a profit in the amount of $ 13.03 Millions.

As for its main indicators, the Company has a P/E ratio of 54.80, a P/BV ratio of 3.18 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker TBPH.

Market value

$ 714.00 Millions

Net worth

$ 224.85 Millions

US$ 224,850,000.00

Assets

$ 426.04 Millions

US$ 426,040,000.00

Total Number of Shares

50.00 Millions

50,000,000

Average Daily Trading Volume

$ 415.58 Thousand

US$ 415,575.62

Sector

Health

Industry

Pharmaceutical Products

TBPH

TBPH revenue and profits

TBPH results

DRAG THE FRAME TO SEE MORE DATA

TBPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

$ - -0,00% (12M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 80.60 50,71% (12M)

P/L

22.89

3.25%

ROE

5.84%

P/VP

1.34

CI - Cigna

$ 299.12 --2,08% (12M)

P/L

15.92

1.97%

ROE

12.41%

P/VP

1.98

CNC - Centene

$ 37.34 --39,56% (12M)

P/L

8.19

0.00%

ROE

7.47%

P/VP

0.61

HUM - Humana

$ 292.67 11,44% (12M)

P/L

22.32

0.91%

ROE

8.61%

P/VP

1.92

SNY - Sanofi

$ 50.68 --0,98% (12M)

P/L

11.23

4.28%

ROE

13.90%

P/VP

1.56

HCA - HCA Healthcare

$ 468.40 31,84% (12M)

P/L

18.04

0.63%

ROE

-482.31%

P/VP

-87.02

LLY - Eli Lilly

$ 813.53 --1,20% (12M)

P/L

53.71

0.70%

ROE

75.21%

P/VP

40.40

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 80.60 50,71% (12 M)

P/L

22.89

3.25%

ROE

5.84%

P/VP

1.34

CI - Cigna

$ 299.12 --2,08% (12 M)

P/L

15.92

1.97%

ROE

12.41%

P/VP

1.98

CNC - Centene

$ 37.34 --39,56% (12 M)

P/L

8.19

0.00%

ROE

7.47%

P/VP

0.61

HUM - Humana

$ 292.67 11,44% (12 M)

P/L

22.32

0.91%

ROE

8.61%

P/VP

1.92

SNY - Sanofi

$ 50.68 --0,98% (12 M)

P/L

11.23

4.28%

ROE

13.90%

P/VP

1.56

HCA - HCA Healthcare

$ 468.40 31,84% (12 M)

P/L

18.04

0.63%

ROE

-482.31%

P/VP

-87.02

LLY - Eli Lilly

$ 813.53 --1,20% (12 M)

P/L

53.71

0.70%

ROE

75.21%

P/VP

40.40

Frequently Asked Questions

What is the price of Theravance Biopharma (TBPH) today?

The price of Theravance Biopharma (TBPH) today is $ 14.17, with a variation of 63.82% compared to the last year. The price of Theravance Biopharma (TBPH) started the year trading around $ 9.41 and today it is at $ 14.17. Follow the real-time price chart, the historical price of Theravance Biopharma (TBPH) and international markets.

When does Theravance Biopharma (TBPH) pay dividends?

Theravance Biopharma (TBPH) did not distribute dividends in the last year.

Is Theravance Biopharma (TBPH) worth it?

Currently, Theravance Biopharma (TBPH) is priced at $ 14.17, with a P/E of 54.80%%, representing a deviation of 670%% from its historical average P/E. In the last year, the stock showed a variation of 63.82% in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%%. The total shareholder return was 63.82%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Theravance Biopharma (TBPH) stock?

Investing in stocks of Theravance Biopharma (TBPH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Theravance Biopharma (TBPH) yield today?

The yield of Theravance Biopharma (TBPH) was -1.80% in the last month, 63.82% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%%.

If you wanted to buy 100 stocks of Theravance Biopharma (TBPH) today, the total investment would be $ 1,417.00, based on the current price of $ 14.17.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 2,321.33
In 5 years: $ 1,417.00
In 10 years: $ 1,417.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

TBPH

Theravance Biopharma Inc.

Price

variation (12m)

p/e

p/bv

DIVIDEND YIELD

Profitability of TBPH

check out the fundamentals of Theravance Biopharma shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Theravance Biopharma

Theravance Biopharma Inc.

Estados Unidos

12 years

2014

359

PROFIT X PRICE TBPH

TBPH results

TBPH cash flow

evolution of assets - TBPH

TBPH balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions